Wednesday, March 25, 2015

Top 5 Healthcare Equipment Stocks To Invest In 2015

Top 5 Healthcare Equipment Stocks To Invest In 2015: Core Laboratories N.V. (CLB)

Core Laboratories N.V. engages in the provision of reservoir description, production enhancement, and reservoir management services to the oil and gas industry worldwide. The company's reservoir description services comprise the characterization of petroleum reservoir rock, fluid, and gas samples; and provision of analytical and field services to characterize properties of crude oil and petroleum products. Its production enhancement products and services relate to reservoir well completions, perforations, stimulations, and production, as well as include integrated services to evaluate the effectiveness of well completions and to develop solutions to increase the effectiveness of enhanced oil recovery projects. The company's reservoir management services consist of the combination and integration of information from reservoir description and production enhancement services to increase production and enhance recovery of oil and gas from clients' reservoirs. Core Laboratori es N.V. markets and sells its services and products through sales representatives, technical seminars, trade shows, and print advertising, as well as through direct sales force, technical experts, operating managers, sales representatives, and distributors in various markets. The company was founded in 1936 and is based in Amsterdam, the Netherlands.

Advisors' Opinion:
  • [By Matt DiLallo]

    Oil prices have taken a beating over the past few months, dragging Core Laboratories N.V. (NYSE: CLB  ) stock down along with them.

  • [By ovenerio]

    The company has a current ROE of 15.65% which is higher than the one exhibit by Superior Energy Services Inc (SPN) and National Oilwell Varco Inc (NOV). In general, analysts consider ROE ratios in the 15-20% range as representing attracti! ve levels for investment. So for investors looking for those levels or more, Oceaneering International (OII) could be the option and Core Laboratories NV (CLB) tremendous ratio seems very attractive. It is very important to understand this metric before investing and it is important to look at the trend in ROE over time.

  • [By Jonas Elmerraji]

    It's been a rough year for shares of Core Laboratories (CLB) -- the oil service company's stock price has fallen more than 21% since the calendar flipped to January this year. So, it's not completely surprising to see that Core Labs came in high on hedge funds' sell lists this past quarter; CLB fell below their "maximum pain threshold", so fund managers clicked "sell". The relevant question for investors is whether it makes sense to follow suit now.

    Core Labs provides oil and gas companies with core and reservoir analysis products and services that help them make better production decisions. That's a pretty easy sell for most of Core Labs' clients: there's a lot of mystery in pulling commodities out of the ground, so the more insight E&P firms can get on their sites, the better. And as oil companies work to pull higher yields out of mature wells, Core Labs' services are even more critical in 2014, a big part of the reason why the firm is able to generate big recurring cash flows each year. Revenues, profits, and margins have stair-stepped higher in each year since the Great Recession, an impressive feat given the shaky trajectory of oil prices.

    Despite excellent execution, CLB's share price has looked rough this year. Technically speaking, shares are in a particularly ugly downtrend that's not showing signs of abating. But the deep value price tag on shares means that it makes sense to jump in on the next sign of a sentiment shift -- I'd call a breakout above the 50-day moving average a solid signal to start buying. Even though hedge funds unloaded 1.64 million shares of CLB last quarter, we're getting close to a low! -risk opp! ortunity to pick them up on the cheap.

    Read More: 5 Breakout Stocks Under $10 Set to Soar

  • source from Top Stocks For 2015:

No comments:

Post a Comment